Carolina Maliska Haack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carolina Maliska Haack has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Débora Tavares de Resendee Silva
Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul (UFFS), Chapecó, Brazil
2 shared publications - Kailane Paula Pretto
Department of Nursing, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil
2 shared publications - Adinei Abadio Soares
Department of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil
1 shared publication - Angela Makeli Kososki Dalagnol
Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul (UFFS), Chapecó, Brazil
1 shared publication - Bernardo Ribeiro Böhm
Department of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil
1 shared publication - BetinaBetina Drehmer da Rosa
Universidade Federal da Fronteira Sul
1 shared publication
Latest Publications
- Open Access
- 24 June 2025
- Published by Universidade Federal do Estado do Rio de Janeiro UNIRIO in Revista de Pesquisa Cuidado é Fundamental Online
- Vol. 17
Palliative care for patients after surgical resection for high-grade central nervous system tumors / Cuidados paliativos para pacientes após ressecção cirúrgica de tumores de alto grau do sistema nervoso central
Objetivo: analisar os cuidados paliativos após ressecção cirúrgica em pacientes com tumores de alto grau do sistema nervoso central. Método: revisão integrativa da literatura realizada nas bases de dados MEDLINE via PubMed, Scopus e Web of Science, sem restrições de idioma ou ano de publicação. Resultados: a análise identificou temas relevantes, como a necessidade de neurocirurgia, alívio de sintomas, subdivisões de cuidado e envolvimento multiprofissional. Destaca-se o impacto positivo dos cuidados paliativos na qualidade de vida dos pacientes e no curso da doença, desde o diagnóstico até o final da vida. Conclusão: cuidados paliativos precoces e bem executados reduzem internações desnecessárias, promovem suporte físico, psicológico, social e espiritual, e beneficiam pacientes e familiares. Recomenda-se a implementação de políticas públicas e programas de treinamento para ampliar o acesso a este cuidado essencial.
- 24 June 2025
- Published by Universidade Federal do Estado do Rio de Janeiro UNIRIO in Revista de Pesquisa Cuidado é Fundamental Online
- Vol. 17
Open AccessPalliative care for patients after surgical resection for high-grade central nervous system tumors / Cuidados paliativos para pacientes após ressecção cirúrgica de tumores de alto grau do sistema nervoso central
Objetivo: analisar os cuidados paliativos após ressecção cirúrgica em pacientes com tumores de alto grau do sistema nervoso central. Método: revisão integrativa da literatura realizada nas bases de dados MEDLINE via PubMed, Scopus e Web of Science, sem restrições de idioma ou ano de publicação. Resultados: a análise identificou temas relevantes, como a necessidade de neurocirurgia, alívio de sintomas, subdivisões de cuidado e envolvimento multiprofissional. Destaca-se o impacto positivo dos cuidados paliativos na qualidade de vida dos pacientes e no curso da doença, desde o diagnóstico até o final da vida. Conclusão: cuidados paliativos precoces e bem executados reduzem internações desnecessárias, promovem suporte físico, psicológico, social e espiritual, e beneficiam pacientes e familiares. Recomenda-se a implementação de políticas públicas e programas de treinamento para ampliar o acesso a este cuidado essencial.
- 1 October 2024
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (3) , 429-446
Purines and purinergic receptors in primary tumors of the central nervous system
Purine nucleotides and nucleosides play critical roles in various pathological conditions, including tumor cell growth. Adenosine triphosphate (ATP) activates pro-tumor receptors, while adenosine (ADO) is a potent immunosuppressant and modulator of cell growth. This study aims to analyze the purinergic actions of ATP and its metabolites, associated enzymes, and P1 or P2 class receptors in primary central nervous system tumors. Additionally, we sought to correlate the levels of nucleosides and the density of P1, P2X, and P2Y receptors in cells with tumor progression. The results indicate that purinergic signaling depends on the receptor concentration and signaling molecules specific to each cell type, tissue, and tumor histology. The purinergic system may function as either a tumor-promoting agent or an antitumor factor, depending on the microenvironmental conditions and the concentrations of receptors and their respective activators. Notably, ATP emerges as the most significant extracellular signal, capable of being converted into other cellular stimulators pertinent to neoplasms, such as adenosine diphosphate, adenosine monophosphate, adenosine, and inosine. Consequently, a cascade of responses to these stimuli promotes tumor development, cell division, and metastasis. Purine nucleotides in central nervous system tumors are pivotal in cellular responses in glioblastoma multiforme, vestibular schwannoma, medulloblastoma, adenomas, gliomas, meningiomas, and pineal tumors. These findings hold the potential for developing novel therapeutic strategies and aiding in therapeutic management. Graphical Abstract
- 1 October 2024
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (3) , 429-446
Purines and purinergic receptors in primary tumors of the central nervous system
Purine nucleotides and nucleosides play critical roles in various pathological conditions, including tumor cell growth. Adenosine triphosphate (ATP) activates pro-tumor receptors, while adenosine (ADO) is a potent immunosuppressant and modulator of cell growth. This study aims to analyze the purinergic actions of ATP and its metabolites, associated enzymes, and P1 or P2 class receptors in primary central nervous system tumors. Additionally, we sought to correlate the levels of nucleosides and the density of P1, P2X, and P2Y receptors in cells with tumor progression. The results indicate that purinergic signaling depends on the receptor concentration and signaling molecules specific to each cell type, tissue, and tumor histology. The purinergic system may function as either a tumor-promoting agent or an antitumor factor, depending on the microenvironmental conditions and the concentrations of receptors and their respective activators. Notably, ATP emerges as the most significant extracellular signal, capable of being converted into other cellular stimulators pertinent to neoplasms, such as adenosine diphosphate, adenosine monophosphate, adenosine, and inosine. Consequently, a cascade of responses to these stimuli promotes tumor development, cell division, and metastasis. Purine nucleotides in central nervous system tumors are pivotal in cellular responses in glioblastoma multiforme, vestibular schwannoma, medulloblastoma, adenomas, gliomas, meningiomas, and pineal tumors. These findings hold the potential for developing novel therapeutic strategies and aiding in therapeutic management. Graphical Abstract